WalkHome
Functional Electrical Stimulation for at Home Rehabilitation
Total Cost €
0EC-Contrib. €
0Partnership
0Views
0WalkHome project word cloud
Explore the words cloud of the WalkHome project. It provides you a very rough idea of what is the project "WalkHome" about.
Project "WalkHome" data sheet
The following table provides information about the project.
| Coordinator |
FESIA TECHNOLOGY SL
Organization address contact info |
| Coordinator Country | Spain [ES] |
| Project website | http://www.fesiatechnology.com/ |
| Total cost | 71˙429 € |
| EC max contribution | 50˙000 € (70%) |
| Programme |
1. H2020-EU.3. (PRIORITY 'Societal challenges) 2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs) 3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies) |
| Code Call | H2020-SMEInst-2018-2020-1 |
| Funding Scheme | SME-1 |
| Starting year | 2018 |
| Duration (year-month-day) | from 2018-06-01 to 2018-09-30 |
Partnership
Take a look of project's partnership.
| # | ||||
|---|---|---|---|---|
| 1 | FESIA TECHNOLOGY SL | ES (DONOSTIA SAN SEBASTIAN) | coordinator | 50˙000.00 |
Map
Project objective
The Context Stroke has huge human and economic cost. 1 million people suffer strokes in Europe every year, with an average life expectancy after stroke of 8 years. Roughly 20% of stroke survivors suffer from drop foot, with 45 billion euros spent on rehabilitating stroke patients in Europe every year. The opportunity: FES offers the tantalising prospect of retraining voluntary motor functions such as walking. However: - FES rehabilitation must be carried out in a hospital with the support of trained healthcare professionals; - Transporting patients and supervising treatment is expensive; - Patient’s treatment plan is sub-optimal; - Per patient rehabilitation costs reach 32,000 euros Our solution: Fesia WalkHome is a FES rehabilitation device for drop foot patients which can be administered by the patient in their own home. This not only reduces costs by 43% but also means patients can have an optimal treatment plan, improving their speed of recovery. The use of Fesia Walk at home will give autonomy, independence and improve the quality of life for chronic patients. It will also mean a substantial reduction of waiting lists, health costs, number of physician office visits, and carer support. The Project: WalkHome represents a disruptive change of paradigm for the FES rehabilitation standard of care. The aim of the phase 1 project is to improve our understanding of the EU market for FES rehabilitation, identifying regional market variations in terms of key decision makers, appropriate business models, pricing structure and identifying which are the most attractive markets for us to use as a beachhead. We will also analyse what key improvements need to be made to the existing technology to create the new FES home care rehabilitation market. The Market: Currently, there is no FES rehabilitation technology that is offered outside of a clinical setting. We estimate that this new home FES rehabilitation market could be worth up to 40 billion euros in Europe alone.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "WALKHOME" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "WALKHOME" are provided by the European Opendata Portal: CORDIS opendata.